SCHEMBL1332729

SCHEMBL1332729

CCCCCCCCCCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O

nearest known ligand 0.89

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 2/20 0.83
▸ EP300 Q09472 3/20 0.80
▸ CHAT P28329 2/20 0.80
▸ AURKA O14965 2/20 0.80
▸ KAT5 Q92993 2/20 0.80
▸ KAT2B Q92831 1/20 0.80
▸ CREBBP Q92793 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2506879 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL1333343 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL31475488 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL2317294 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL380634 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL380100 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL25273107 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL11026148 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL2510648 1.00 NAA50 (0.83) NAA50EP300CHATAURKAKAT5
SCHEMBL30558687 0.99 NAA50 (0.84) NAA50EP300CHATAURKAKAT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388910-A1 METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL AGAIN BIO APS (DK) 2025-12-25 — — US disclosed
US-12398396-B2 Methods for enhancing microbial production of specific length fatty alcohols in the presence of methanol GENOMATICA, INC. (US) 2025-08-26 — — US disclosed
EP-3074504-B1 METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL GENOMATICA INC (US) 2024-12-25 — — EP disclosed
CN-115960720-A Microorganisms and methods for producing fatty alcohols of specific length and related compounds 基因组股份公司 2023-04-14 — — CN disclosed
CN-104884629-B Microorganisms and methods for producing fatty alcohols of specific length and related compounds 基因组股份公司 2022-12-20 — — CN disclosed
US-20220348932-A1 METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL AGAIN BIO APS (DK) 2022-11-03 — — US disclosed
US-20220333143-A1 MICROORGANISMS AND METHODS FOR PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS AND RELATED COMPOUNDS GENOMATICA INC (US) 2022-10-20 — — US disclosed
US-20220220511-A1 MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY FORMATE ASSIMILATION GENOMATICA INC (US) 2022-07-14 — — US disclosed
US-11186853-B2 Microorganisms and methods for production of specific length fatty alcohols and related compounds GENOMATICA, INC. (US) 2021-11-30 — — US disclosed
US-20210238609-A1 MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY FORMATE ASSIMILATION GENOMATICA INC (US) 2021-08-05 — — US disclosed
WO-2014152434-A2 MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY FORMATE ASSIMILATION GENOMATICA, INC. (US) 2014-09-25 — — WO disclosed
US-20140127765-A1 MICROORGANISMS AND METHODS FOR PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS AND RELATED COMPOUNDS GENOMATICA, INC. (US) 2014-05-08 — — US disclosed
WO-2014062564-A1 MICROORGANISMS AND METHODS FOR PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS AND RELATED COMPOUNDS GENOMATICA, INC. (US) 2014-04-24 — — WO disclosed
US-20130122541-A1 MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS THE REGENTS OF THE UNIVERSITY OF COLORADO 2013-05-16 — — US disclosed
EP-2529023-A1 MICROORGANISM PRODUCTION OF HIGH-VALVE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS OPX Biotechnologies Inc. (US) 2012-12-05 — — EP disclosed
US-20120191434-A1 ARTICLES OF MANUFACTURE AND METHODS FOR MODELING CHINESE HAMSTER OVARY (CHO) CELL METABOLISM GT LIFE SCIENCES, INC. (US) 2012-07-26 — — US disclosed
US-20110282587-A1 COMPUTER READABLE STORAGE MEDIUMS, METHODS AND SYSTEMS FOR NORMALIZING CHEMICAL PROFILES IN BIOLOGICAL OR MEDICAL SAMPLES DETECTED BY MASS SPECTROMETRY EMORY UNIVERSITY (US) 2011-11-17 — — US disclosed
US-20110246081-A1 Metabolomics-Based Identification of Disease-Causing Agents GEORGIA TECH RESEARCH CORPORATION (US) 2011-10-06 — — US disclosed
WO-2011094457-A1 MICROORGANISM PRODUCTION OF HIGH-VALVE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS OPX BIOTECHNOLOGIES, INC. (US) 2011-08-04 — — WO disclosed
EP-2230312-A1 Probe compound for detecting and isolating enzymes and means and methods using the same Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2010-09-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11186853-B2 Microorganisms and methods for production of specific length fatty alcohols and related compounds ADH5, FASN, ACADM NAA50 160/4885EP300 514/4885CHAT 1120/4885
US-20250388910-A1 METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL ADH5, ADH1C, ADH1A NAA50 426/4885EP300 1466/4885CHAT 1999/4885
US-20220333143-A1 MICROORGANISMS AND METHODS FOR PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS AND RELATED COMPOUNDS ADH5, FASN, ACADM NAA50 160/4885EP300 514/4885CHAT 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback